Rebif (interferon beta-1a) is a prescription drug used to treat types of multiple sclerosis. Rebif can cause side effects that range from mild to serious. Examples ...
Rebif injections are given three times per week for multiple sclerosis (MS) and clinically isolated syndrome (CIS). You’ll start with a low dose of Rebif for the first 4 weeks of treatment. Your ...
Rebif (interferon beta-1a) is a brand-name injectable solution prescribed for multiple sclerosis (MS) in adults. The medication comes in prefilled syringes and auto ...
Merck acquired Rebif through its merger with Serono and had hoped to improve the drug’s market share by demonstrating superiority over Copaxone; sales of Rebif in the first quarter of this year alone ...
REBIF REBIDOSE (interferon beta-1a) 8.8mcg/0.2mL, 22mcg/0.5mL, 44mcg/0.5mL inj by EMD Serono, Pfizer EMD Serono and Pfizer announced that the FDA has approved Rebif Rebidose (interferon beta-1a), a ...
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that new pregnancy outcomes data in women with MS treated with interferon beta (IFN β), including ...
With oral rivals lurking for Rebif, the leading drug from Merck KGaA, the good news for the German pharma is that the news isn't that bad. Sales of the med, used to treat relapsing forms of multiple ...
DARMSTADT, Germany, October 18, 2017/PRNewswire/. Merck, a leading science and technology company, today announced that data for approved and investigational multiple sclerosis (MS) treatments, ...
On September 20, the European Commission approved 30- and 45-mg strengths of oseltamivir phosphate capsules (Tamiflu, Hoffmann-La Roche Ltd) for the treatment and prevention of influenza types A and B ...
Rebif (interferon beta-1a) is a brand-name injection that’s prescribed for certain types of multiple sclerosis (MS). As with other drugs, Rebif can cause side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results